Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Celtaxsys’ cystic fibrosis drug reduces lung exacerbations in phase 2 study

fiercebiotechAugust 03, 2018

Tag: Celtaxsys , cystic fibrosis

PharmaSources Customer Service